Drug Shortage Report for RANITIDINE
| Report ID | 120756 |
| Drug Identification Number | 00740756 |
| Brand name | RANITIDINE |
| Common or Proper name | RANITIDINE - 300 |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-07-22 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-07-23 |
| Company comments | Regulatory issues, Enjeux règlementaires |
| Health Canada comments | |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-07-23 | English | Compare |
| v2 | 2020-07-22 | French | Compare |
| v1 | 2020-07-22 | English | Compare |